BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30400802)

  • 1. Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.
    Lapin M; Oltedal S; Tjensvoll K; Buhl T; Smaaland R; Garresori H; Javle M; Glenjen NI; Abelseth BK; Gilje B; Nordgård O
    J Transl Med; 2018 Nov; 16(1):300. PubMed ID: 30400802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer.
    Liu X; Liu L; Ji Y; Li C; Wei T; Yang X; Zhang Y; Cai X; Gao Y; Xu W; Rao S; Jin D; Lou W; Qiu Z; Wang X
    EBioMedicine; 2019 Mar; 41():345-356. PubMed ID: 30857943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
    Karachaliou N; Mayo-de las Casas C; Queralt C; de Aguirre I; Melloni B; Cardenal F; Garcia-Gomez R; Massuti B; Sánchez JM; Porta R; Ponce-Aix S; Moran T; Carcereny E; Felip E; Bover I; Insa A; Reguart N; Isla D; Vergnenegre A; de Marinis F; Gervais R; Corre R; Paz-Ares L; Morales-Espinosa D; Viteri S; Drozdowskyj A; Jordana-Ariza N; Ramirez-Serrano JL; Molina-Vila MA; Rosell R;
    JAMA Oncol; 2015 May; 1(2):149-57. PubMed ID: 26181014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer.
    Spindler KL; Appelt AL; Pallisgaard N; Andersen RF; Brandslund I; Jakobsen A
    Int J Cancer; 2014 Dec; 135(12):2984-91. PubMed ID: 24798213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Free DNA and Clinical Characteristics in Patients with Small Intestinal or Pancreatic Neuroendocrine Tumors.
    Oversoe SK; Sorensen BS; Tabaksblat EM; Gronbaek H; Kelsen J
    Neuroendocrinology; 2022; 112(1):43-50. PubMed ID: 33461190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free DNA as a biomarker for colorectal cancer: a retrospective analysis in patients before and after surgery.
    Zhong Y; Zhou Q; Zhang Y; Zhou S; Zhang G; Jiang C; Zhang Z; Zhang X; Xu J; Jin C; Cao L; Chen L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):135-141. PubMed ID: 32415940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
    Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Chu C; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Chan JM; Friedlander T; Wyatt AW; Aggarwal R; Paris PL; Carroll PR; Feng F; Witte JS
    Sci Rep; 2021 Mar; 11(1):5040. PubMed ID: 33658587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.
    Hur JY; Kim YJ; Yoon SE; Son DS; Park WY; Kim SJ; Park D; Kim WS
    Ann Hematol; 2020 Jun; 99(6):1293-1302. PubMed ID: 32296914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
    Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
    Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation status and long-fragment cell-free DNA are prognostic biomarkers for gastric cancer.
    Ko K; Kananazawa Y; Yamada T; Kakinuma D; Matsuno K; Ando F; Kuriyama S; Matsuda A; Yoshida H
    Cancer Med; 2021 Mar; 10(6):2003-2012. PubMed ID: 33641249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer.
    Cheng J; Holland-Letz T; Wallwiener M; Surowy H; Cuk K; Schott S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Burwinkel B
    Breast Cancer Res Treat; 2018 May; 169(1):69-82. PubMed ID: 29340881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
    Ai B; Liu H; Huang Y; Peng P
    Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
    Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer.
    Lin LH; Chang KW; Kao SY; Cheng HW; Liu CJ
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis.
    Chen L; Zhang Y; Cheng Y; Zhang D; Zhu S; Ma X
    Gene; 2018 Dec; 679():328-334. PubMed ID: 30227250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragmentation of cell-free DNA is induced by upper-tract urothelial carcinoma-associated systemic inflammation.
    Nakano K; Yamamoto Y; Yamamichi G; Yumiba S; Tomiyama E; Matsushita M; Koh Y; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Fujita K; Nonomura N; Uemura M
    Cancer Sci; 2021 Jan; 112(1):168-177. PubMed ID: 33027843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
    Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the efficacy of immunotherapy by measuring the integrity of cell-free DNA in plasma in colorectal cancer.
    Kitahara M; Hazama S; Tsunedomi R; Takenouchi H; Kanekiyo S; Inoue Y; Nakajima M; Tomochika S; Tokuhisa Y; Iida M; Sakamoto K; Suzuki N; Takeda S; Ueno T; Yamamoto S; Yoshino S; Nagano H
    Cancer Sci; 2016 Dec; 107(12):1825-1829. PubMed ID: 27663862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.